Clinical Trials Contact

About this Clinical Trial

A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)

Your Message Will Go To

SPECTRUM

650-725-4341


All fields are required. *

Preferred contact method*

To:

SPECTRUM

650-725-4341



Go Back To The Trial

We were not able to send your contact info at this time.

Go Back To The Trial

©2022 Stanford Medicine